Guangzhou Yuanyuanxia Import and Export Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Guangzhou Yuanyuanxia Import and Export Trading Co., Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 0 trademarks are registered and 1 is pending. The owner is based in Guangzhou.

X1301-I4925(Building No. 1)

Guangzhou 510000 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Guangzhou Yuanyuanxia Import and Export Trading Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Guangzhou Yuanyuanxia Import and Export Trading Co., Ltd. have?

Guangzhou Yuanyuanxia Import and Export Trading Co., Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 1 pending, 2 abandoned.

What trademark classes does Guangzhou Yuanyuanxia Import and Export Trading Co., Ltd. file in?

Guangzhou Yuanyuanxia Import and Export Trading Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What is Guangzhou Yuanyuanxia Import and Export Trading Co., Ltd.'s trademark registration success rate?

Guangzhou Yuanyuanxia Import and Export Trading Co., Ltd. has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.